BlackRock increased its holdings of Medicinal Kangde (02359) by about 337,600 shares at a price of approximately HK$198.87 per share

The Zhitong Finance App learned that the latest data from the Hong Kong Stock Exchange shows that on August 12, BlackRock increased its holdings of Pharmaceutical Kant (02359) by 337.637 million shares, at a price of HK$198.8658 per share, for a total amount of about HK$67.144,500. After the increase in holdings, the latest number of shares held was approximately 30.64,800 shares, and the latest shareholding ratio was 6%.